First Time Loading...
C

Celltrion Healthcare Co Ltd
KOSDAQ:091990

Watchlist Manager
Celltrion Healthcare Co Ltd
KOSDAQ:091990
Watchlist
Price: 75 900 KRW -5.6% Market Closed
Updated: May 14, 2024

Balance Sheet

Balance Sheet Decomposition
Celltrion Healthcare Co Ltd

Current Assets 4.5T
Cash & Short-Term Investments 433.4B
Receivables 1.3T
Other Current Assets 2.7T
Non-Current Assets 182.2B
Long-Term Investments 2.8B
PP&E 10.3B
Intangibles 12.3B
Other Non-Current Assets 156.8B
Current Liabilities 2.5T
Accounts Payable 1.7T
Accrued Liabilities 87.5B
Short-Term Debt 292.5B
Other Current Liabilities 447.2B
Non-Current Liabilities 135.8B
Long-Term Debt 4.6B
Other Non-Current Liabilities 131.3B

Balance Sheet
Celltrion Healthcare Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
4 426
36 861
95 867
251 366
240 369
296 966
231 494
254 941
458 004
Cash
11
5
14
15
14
3
0
0
0
Cash Equivalents
4 415
36 856
95 853
251 351
240 355
296 963
231 494
254 941
458 004
Short-Term Investments
0
0
0
520 000
330 708
160 621
295 695
267 130
71 088
Total Receivables
40 852
62 152
364 283
420 530
448 218
549 230
847 621
977 397
1 220 821
Accounts Receivables
40 781
62 089
364 147
418 753
446 614
518 438
750 503
925 259
1 016 672
Other Receivables
71
63
136
1 777
1 604
30 792
97 118
52 138
204 150
Inventory
1 186 797
1 399 285
1 472 120
1 574 799
1 696 910
1 623 600
2 034 551
2 065 737
2 352 890
Other Current Assets
9 731
14 164
16 883
33 526
77 172
35 854
89 501
137 536
172 864
Total Current Assets
1 241 806
1 512 462
1 949 153
2 800 221
2 793 377
2 666 271
3 498 862
3 702 742
4 275 666
PP&E Net
345
193
112
315
362
2 394
6 211
7 116
9 416
PP&E Gross
345
193
112
315
362
2 394
6 211
7 116
9 416
Accumulated Depreciation
547
705
842
917
1 002
2 447
3 678
5 584
8 041
Intangible Assets
119
221
282
1 338
2 152
1 906
3 820
3 829
6 392
Goodwill
734
734
734
734
734
734
734
734
6 200
Note Receivable
34 137
30 740
2 142
3 973
4 152
0
0
6
192
Long-Term Investments
0
18 882
23 100
50 285
32 658
27 072
3 983
4 384
2 256
Other Long-Term Assets
106 558
12 293
11 918
18 079
115 135
150 529
226 088
195 883
154 476
Other Assets
734
734
734
734
734
734
734
734
6 200
Total Assets
1 383 699
N/A
1 575 526
+14%
1 987 441
+26%
2 874 946
+45%
2 948 569
+3%
2 848 905
-3%
3 739 698
+31%
3 914 694
+5%
4 454 599
+14%
Liabilities
Accounts Payable
326 027
580 201
641 305
659 243
646 329
570 678
955 355
736 087
1 441 494
Accrued Liabilities
18 296
11 033
5 032
7 468
1 795
22 297
95 634
24 893
148 633
Short-Term Debt
10 993
9 360
22 666
11 269
16 824
114 429
197 634
398 927
358 658
Current Portion of Long-Term Debt
165 922
5 789
166 109
0
0
1 147
2 232
2 417
3 681
Other Current Liabilities
531 780
93 892
308 260
315 364
614 187
362 522
406 919
481 889
292 436
Total Current Liabilities
1 053 018
700 275
1 143 372
993 344
1 279 135
1 071 072
1 657 774
1 644 213
2 244 902
Long-Term Debt
144 604
154 563
0
0
0
788
3 053
3 535
4 309
Deferred Income Tax
0
0
0
161
232
4
41 492
61 431
61 442
Minority Interest
0
0
0
0
0
0
0
0
0
Other Liabilities
870 748
221 010
195 416
173 967
33 723
111 147
104 449
99 748
82 154
Total Liabilities
2 068 370
N/A
1 075 847
-48%
1 338 788
+24%
1 167 472
-13%
1 313 091
+12%
1 183 011
-10%
1 806 769
+53%
1 808 927
+0%
2 392 807
+32%
Equity
Common Stock
1 658
2 772
112 084
137 338
140 527
143 928
151 810
155 028
158 242
Retained Earnings
797 244
776 660
205 603
264 698
267 463
329 641
562 932
712 496
816 753
Additional Paid In Capital
144 211
1 323 556
380 642
1 365 601
1 377 026
1 390 657
1 408 552
1 412 551
1 417 272
Unrealized Security Profit/Loss
0
0
0
0
0
7
167
11
89
Treasury Stock
0
0
0
0
96 165
114 060
116 968
128 592
219 641
Other Equity
33 296
49 990
49 677
60 164
53 371
84 279
73 229
45 726
110 924
Total Equity
684 671
N/A
499 679
N/A
648 653
+30%
1 707 473
+163%
1 635 478
-4%
1 665 894
+2%
1 932 930
+16%
2 105 768
+9%
2 061 791
-2%
Total Liabilities & Equity
1 383 699
N/A
1 575 526
+14%
1 987 441
+26%
2 874 946
+45%
2 948 569
+3%
2 848 905
-3%
3 739 698
+31%
3 914 694
+5%
4 454 599
+14%
Shares Outstanding
Common Shares Outstanding
74
124
125
153
152
152
153
159
161

See Also

Discover More